Aggressive chemotherapy in frail patients with diffuse large B-cell lymphoma: The role of pegylated liposomal doxorubicin

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Frail Patients ◽

Combination of albumin-bound paclitaxel and pegylated liposomal doxorubicin is effective in treatment of heavily treated relapsed/refractory diffuse large B-cell lymphoma: a case report

Leukemia & Lymphoma ◽

10.3109/10428194.2013.776166 ◽

2013 ◽

Vol 54 (11) ◽

pp. 2553-2555 ◽

Cited By ~ 2

Author(s):

Liang Wang ◽

Zhong-Jun Xia

Keyword(s):

Case Report ◽

B Cell ◽

Liposomal Doxorubicin ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Activity and toxicity of pegylated liposomal doxorubicin in combination regimen (DRCOP) for patients >60 years old with untreated diffuse large B cell lymphoma (DLBCL): A phase II study

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.20505 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 20505-20505

Author(s):

M. A. Rodriguez ◽

M. Fanale ◽

F. B. Hagemeister ◽

P. McLaughlin ◽

B. Pro ◽

...

Keyword(s):

B Cell ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Combination Regimen ◽

Large B Cell Lymphoma ◽

Efficacy and safety of cyclophosphamide, doxorubicin, vincristine, and prednisone regimen with pegylated liposomal doxorubicin±rituximab in treating diffuse large B-cell lymphoma

Minerva Medica ◽

10.23736/s0026-4806.19.06236-0 ◽

2021 ◽

Vol 112 (2) ◽

Author(s):

Yuhuan GAO ◽

Yan XIE ◽

Lihong LIU ◽

Hongwei XUE ◽

Ming HOU ◽

...

Keyword(s):

B Cell ◽

Liposomal Doxorubicin ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Efficacy And Safety ◽

Large B Cell Lymphoma ◽

Phase II study of RCHOP with pegylated liposomal doxorubicin (DRCOP) for patients older than age 60 with untreated diffuse large B-cell lymphoma (DLBCL).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.8053 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 8053-8053

Author(s):

M. A. Rodriguez ◽

J. Durand ◽

A. B. Astrow ◽

M. J. Bury ◽

M. A. Fanale ◽

...

Keyword(s):

B Cell ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

New tricks for old drugs: combination of rituximab and two nanoparticle-delivered chemotherapy drugs, albumin-bound paclitaxel and pegylated liposomal doxorubicin, in the treatment of relapsed/refractory diffuse large B cell lymphoma

Leukemia & Lymphoma ◽

10.1080/10428194.2020.1775206 ◽

2020 ◽

Vol 61 (10) ◽

pp. 2502-2506

Author(s):

Liang Wang ◽

Xiao-qin Chen ◽

Zhong-jun Xia

Keyword(s):

B Cell ◽

Liposomal Doxorubicin ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Chemotherapy Drugs ◽

Large B Cell Lymphoma ◽

Old Drugs ◽

Pegylated Liposomal Doxorubicin in Combination Chemotherapy in the Treatment of Previously Untreated Aggressive Diffuse Large-B-Cell Lymphoma

Medical Oncology ◽

10.1385/mo:19:1:55 ◽

2002 ◽

Vol 19 (1) ◽

pp. 55-58 ◽

Cited By ~ 15

Author(s):

Agustin Avilés ◽

Natividad Neri ◽

Claudia Castañeda ◽

Alejandra Talavera ◽

Judith Huerta-Guzmán ◽

...

Keyword(s):

B Cell ◽

Combination Chemotherapy ◽

Liposomal Doxorubicin ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

CHOP-rituximab with pegylated liposomal doxorubicin for the treatment of elderly patients with diffuse large B-cell lymphoma

Leukemia & Lymphoma ◽

10.1080/10428190600799946 ◽

2006 ◽

Vol 47 (10) ◽

pp. 2174-2180 ◽

Cited By ~ 27

Author(s):

F. Zaja ◽

V. Tomadini ◽

A. Zaccaria ◽

M. Lenoci ◽

M. Battista ◽

...

Keyword(s):

Elderly Patients ◽

B Cell ◽

Liposomal Doxorubicin ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Non-pegylated liposomal doxorubicin based on treatment of diffuse large B cell lymphoma in old patient with increased cardiovascular risk – case report and review of literature

Oncoreview ◽

10.24292/01.or.080119 ◽

2019 ◽

Vol 8 (4) ◽

pp. 120-126 ◽

Cited By ~ 1

Author(s):

Monika Joks ◽

Monika Urbaniak

Keyword(s):

Case Report ◽

Cardiovascular Risk ◽

B Cell ◽

Liposomal Doxorubicin ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Review Of Literature ◽

Large B Cell Lymphoma ◽

Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma

European Journal of Cancer ◽

10.1016/j.ejca.2016.02.004 ◽

2016 ◽

Vol 58 ◽

pp. 112-121 ◽

Cited By ~ 26

Author(s):

Michael A. Fridrik ◽

Ulrich Jaeger ◽

Andreas Petzer ◽

Wolfgang Willenbacher ◽

Felix Keil ◽

...

Keyword(s):

B Cell ◽

Liposomal Doxorubicin ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Frontline Treatment ◽

Prognostication of High-Grade Diffuse Large B-Cell Lymphoma and the Role of MYC, BCL2, and Phosphohistone H3

American Journal of Clinical Pathology ◽

10.1093/ajcp/144.suppl2.145 ◽

2015 ◽

Vol 144 (suppl 2) ◽

pp. A145-A145

Author(s):

Qian Dai ◽

Shuko Harada ◽

Deniz Peker

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

High Grade ◽

Large B Cell Lymphoma ◽

Phosphohistone H3 ◽